MedPath

Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy

Completed
Conditions
Carcinoma, Hepatocellular
Registration Number
NCT04903340
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

Post-processing of Positron Emission Tomography (PET) acquired images, performed following radioembolization treatment with microspheres at 90Y in hepatocellular carcinoma patients, is subject to changes commercialized by General Electric : respiratory motion correction, specific reconstruction algorithms. We propose to test the possible combinations of these reconstruction parameters to determine which ones to apply for an optimal quality exam with the shortest scan time possible

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • patient with hepatocellular carcinoma
  • with radioembolization treatment decided
  • over the age of 18
Exclusion Criteria
  • radiembolization not possible
  • acquisition of PET/CT imaging at 90Y not possible

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Average dose value (Gy) of tumor liver and healthy liver obtained according to reconstruction configuration.Day 0 (PET/CT Exam)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Bordeaux

🇫🇷

Bordeaux, France

CHU Bordeaux
🇫🇷Bordeaux, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.